in

EQT, Biontech investor household take into account Sandoz bid

© Reuters. FILE PHOTO: A normal view of the BioNTech constructing the place the manufacturing of the coronavirus illness (COVID-19) vaccine has began in Marburg, Germany, November 18, 2021. REUTERS/Fabian Bimmer

ZURICH (Reuters) – Funding group EQT (NYSE:) and members of the Struengmann household, who’re buyers in Biontech, are contemplating a joint bid for Swiss pharmaceutical group Novartis’s generics division Sandoz, German newspaper Handelsblatt reported on Friday, citing unnamed sources.

A possible provide may worth Sandoz at greater than 20 billion Swiss francs ($21.58 billion), the newspaper reported.

Novartis in October raised the prospect of divesting Sandoz after years of revamping the enterprise, as value pressures mount within the off-patent drug sector.

It stated on the time it had begun a strategic evaluation which might “discover all choices, starting from retaining the enterprise to separation, with a purpose to decide how one can finest maximize worth for our shareholders”.

The Struengmann household and EQT, who’ve already made a number of joint investments, have been seeking to convey additional buyers on board as a consortia for a possible deal, Handelsblatt reported.

EQT declined remark. Novartis didn’t instantly reply to requests by telephone and e mail for remark.

The Swiss drugmaker in 2019 spun off its eyecare division Alcon (NYSE:), marking the biggest Swiss inventory deal in a decade when it made its debut with a market capitalisation of greater than $25 billion.

($1 = 0.9268 Swiss francs)

Disclaimer: Fusion Media want to remind you that the information contained on this web site is just not essentially real-time nor correct. All CFDs (shares, indexes, futures) and Foreign exchange costs aren’t supplied by exchanges however relatively by market makers, and so costs might not be correct and should differ from the precise market value, which means costs are indicative and never acceptable for buying and selling functions. Due to this fact Fusion Media doesn`t bear any duty for any buying and selling losses you may incur on account of utilizing this information.

Fusion Media or anybody concerned with Fusion Media won’t settle for any legal responsibility for loss or harm on account of reliance on the knowledge together with information, quotes, charts and purchase/promote alerts contained inside this web site. Please be totally knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is likely one of the riskiest funding types potential.


What do you think?

Written by colin

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Noah Sheer promoted to Government Vice President and Head of Promotion at Def Jam Recordings

McKinsey funding fund fined $18m by SEC for compliance lapses